Recurrent Acute Myeloid Leukemia Early After Kidney Transplantation (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO1053; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He received a deceased donor KTX in June 2025 with basiliximab induction and maintenance with tacrolimus, mycophenolate mofetil, and prednisone. AML relapse after HSCT carries a poor prognosis and no clear guidelines exist for KTX candidacy. Registry data for similar rare cohorts are needed to better understand post-KTX outcomes."
Acute Myelogenous Leukemia • Bone Marrow Transplantation • Chronic Kidney Disease • Diabetes • Diabetic Nephropathy • Hematological Malignancies • Leukemia • Metabolic Disorders • Solid Organ Transplantation • Transplantation
|